| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 108 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 106 |
| 2 | TACROLIMUS OINTMENT 0.1% | 106 |
| 3 | PREDNISONE | 69 |
| 4 | MYCOPHENOLATE MOFETIL | 64 |
| 5 | MYCOPHENOLIC ACID | 27 |
| 6 | MYCOPHENILIC ACID | 21 |
| 7 | METHYLPREDNISOLONE | 16 |
| 8 | PREDNISOLONE | 16 |
| 9 | PREDNISOLONE ORAL | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENTAMIDINE ISETHIONATE | 7 | 0.0056 |
| 1 | TAFASITAMAB-CXIX | 4 | 0.0044 |
| 2 | RIFABUTIN | 5 | 0.0018 |
| 3 | RIFAMPICIN | 11 | 0.0011 |
| 4 | MYCOPHENILIC ACID | 21 | 0.0010 |
| 5 | TACROLIMUS OINTMENT 0.1% | 106 | 0.0008 |
| 6 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 106 | 0.0008 |
| 7 | MYCOPHENOLIC ACID | 27 | 0.0008 |
| 8 | CHLORAMBUCIL | 3 | 0.0008 |
| 9 | MOXIFLOXACIN HYDROCHLORIDE | 15 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Rifamycin Antimycobacterial [EPC] | 5 | 0.0014 |
| 1 | Antimetabolite Immunosuppressant [EPC] | 21 | 0.0010 |
| 2 | Penem Antibacterial [EPC] | 14 | 0.0004 |
| 3 | CD19-directed Chimeric Antigen Receptor [EPC] | 4 | 0.0004 |
| 4 | Oxazolidinone Antibacterial [EPC] | 11 | 0.0004 |
| 5 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 8 | 0.0004 |
| 6 | Glycopeptide Antibacterial [EPC] | 17 | 0.0003 |
| 7 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 11 | 0.0002 |
| 9 | Macrolide Antimicrobial [EPC] | 10 | 0.0002 |